Opendata, web and dolomites


A hands-free remote monitoring solution for continuous and accurate medical grade assessment of heart health

Total Cost €


EC-Contrib. €






 wellwatch project word cloud

Explore the words cloud of the wellwatch project. It provides you a very rough idea of what is the project "wellwatch" about.

equates    trip    electrocardiogram    self    model    sensors    supply    clinically    private    historically    solutions    remote    ecg    12    mobile    wet    successful    time    cvd    250    patient    80    wellwatch    global    41tn    proposition    acceptable    costly    transmits    signals    health    attractive    disease    estimates    premature    4m    smart    snapshot    annually    medical    platform    secure    prognosis    truly    first    follow    business    death    complete    chain    clinician    projections    onset    heart    smartlife    centric    worth    2021    entry    assisting    2019    preventable    electronics    99bn    9bn    textiles    monitoring    size    textile    validated    save    gain    diagnosis    medically    contactless    patented    forecast    mover    cardiovascular    consuming    innovation    provides    commercialisation    market    primary    treatment    garment    initial    suppliers    doctor    predictive    hospitals    care    hub    healthcare    faster    hospital    wearable    roi    route    ec    licensees    disruptive    25    deaths    advantage    feasibility    economically    770   

Project "wellwatch" data sheet

The following table provides information about the project.


Organization address
city: LEEDS
postcode: LS18 5NT
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2017-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SMARTLIFEINC LIMITED UK (LEEDS) coordinator 50˙000.00


 Project objective

Cardiovascular disease (CVD) is the leading cause of death in the EU with over 4m deaths annually. Although up to 80% of premature deaths are preventable through early prognosis and treatment the associated costs are significant with global estimates of €41tn in the next 25 years. There is an increasing focus on making care more patient-centric which could save €99bn in healthcare costs in the EU annually.

Currently the only medically acceptable method of monitoring a CVD condition includes a trip to the hospital, a complete 12 lead ‘wet’ electrocardiogram (ECG) and a follow-up with a doctor. This process is time-consuming, costly to hospitals and provides only a snapshot of a patient’s heart health.

At Smartlife, we have developed wellwatch; a wearable technology garment with our patented textile sensors built in and our unique contactless electronics hub that transmits signals to a mobile application for remote monitoring by patient and clinician. Our technology can be truly disruptive – assisting in the diagnosis of early onset or predictive heart conditions.

To gain first mover advantage in the challenging medical market we must secure our supply chain, fully develop the care pathway and present an attractive value proposition to licensees and suppliers. We expect our initial route to market will be through private healthcare, as historically they have a faster uptake of novel solutions. The primary aim of our overall innovation project is to develop a clinically and economically validated wellwatch platform for self-monitoring of CVD. The objective of this feasibility study is to develop our business model for successful commercialisation of wellwatch.

The market size of smart textiles in medical applications is forecast to be worth €0.9bn by 2021; our growth projections for wellwatch are to achieve a 5-year ROI of 250% for Smartlife following market entry in 2019, based on our estimated project costs this equates to an ROI of 770% to the EC.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "WELLWATCH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "WELLWATCH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More